Recurrent lupus nephritis post-transplant may go undetected without surveillance biopsies. This study reveals high recurrence ...

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 6, 2025, the Compensation Committee granted inducement ...

FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.

There is no established diet for lupus. However, eating some foods and avoiding others may help you manage your symptoms.

In light of recent federal research funding cuts, the Arthritis Foundation and CARRA each contributed an additional $100,000 to support the grant program this year. Meanwhile, demand for research ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

Complete Milk (Class III) Oct 2025 futures overview by Barron's. View the DAV25 futures and commodity market news with real-time price data for better-informed trading.

What this study adds It remains unclear how the presence of lupus nephritis (LN) will impact on risk factors and complications of CVD in patients with SLE. While several studies have reported CVD ...

FIDELITY MIP II: CLASS III- Performance charts including intraday, historical charts and prices and keydata.

PRUDENTIAL SERIES FUND GOVERNMENT MONEY MARKET PORTFOLIO CLASS III- Performance charts including intraday, historical charts and prices and keydata.